Search for publications in the Transfection Database with Polyplus transfection reagents or for transfection conditions.

Over 6000 publications, 1000 cell lines and primary cells available.

Order by :  
Found 5890 results :
Cell Linein vitro
in vivo
Delivered MoleculeReagentResults & Citations
Hep G2, Huh7in vitroDNAjetPEI
Sirvent, A. et al. (2004)

J Lipid Res 45, 2110-5
Farnesoid X receptor represses hepatic lipase gene expression
More details
HEK-293in vitroDNAjetPRIME
Siuda, E. R. et al. (2015)

Neuron 86, 923-35
Spatiotemporal control of opioid signaling and behavior
More details
MG-63in vitromimic miRNAINTERFERin
Skarn, M. et al. (2013)

PLoS ONE 8, e79231
Epigenetic regulation and functional characterization of microRNA-142 in mesenchymal cells
More details
SMAin vitroDNAjetPEI
Skordis, L. A. et al. (2003)

Proc Natl Acad Sci U S A 100, 4114-9
Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts
More details
NIH/3T3in vitroDNAjetPEI
Smagulova, F. et al. (2005)

J Mol Biol 354, 1118-28
The highly structured encapsidation signal of MuLV RNA is involved in the nuclear export of its unspliced RNA
More details
HEK-293Tin vitroDNA, siRNAINTERFERin, jetPEI
Smal, C. et al. (2010)

Arch Biochem Biophys 502, 44-52
Casein kinase 1delta activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity
More details
HEK-293Tin vitroDNAjetPEI
Smal, C. et al. (2006)

J Biol Chem 281, 4887-93
Identification of in vivo phosphorylation sites on human deoxycytidine kinase. Role of Ser-74 in the control of enzyme activity
More details
MDA-MB-231, SNB-19in vitrosiRNAINTERFERin
Smith, H. W. et al. (2008)

J Cell Biol 182, 777-90
uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180
More details
A375, SK-MEL-2, WM164, WM266.4in vitrosiRNAINTERFERin
Smith, M. P. et al. (2013)

J Natl Cancer Inst 105, 33-46
Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma
More details
A375, WM266.4in vitrosiRNAINTERFERin
Smith, M. P. et al. (2014)

Cancer Discov 4, 1214-29
The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFalpha
More details